Celator Pharmaceuticals, Inc. is an oncology-focused biopharmaceutical company that is transforming the science of combination therapy by creating a more effective way of studying, optimizing and delivering a new generation of combination products to improve outcomes for cancer patients. Our vision is to establish a new treatment paradigm in which rationally-designed, fully-integrated combination products replace combination regimens of individual agents.